Anti-CD86 antibody [EPR22958-106]
- 20ul selling size
- RabMAb
- Recombinant
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(8 제품이 사용된 논문 )
Rabbit Recombinant Monoclonal CD86 antibody. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 8 publications.
대체 명칭 보기
CD86, T-lymphocyte activation antigen CD86, Activation B7-2 antigen, Early T-cell costimulatory molecule 1, ETC-1, Cd86
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD86 antibody [EPR22958-106] (AB242142)
Flow cytometric analysis of Mouse splenocytes (treated with 1 ug/ml lipopolysaccharide (LPS) for 3 days) labelling CD86 with ab242142 at 1/600 (Right) compared with a Rabbit monoclonal IgG (ab172730) isotype control (Left). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 was used as the secondary antibody.
Cells were stained with rabbit IgG (Left) or ab242142 (Right). Then stained with anti-CD19 conjugated to Alexa Fluor® 647.
Gated on viable cells.
- Flow Cyt
Lab
Flow Cytometry - Anti-CD86 antibody [EPR22958-106] (AB242142)
Flow cytometry overlay histogram showing mouse splenocytes treated with 1µg/ml LPS for 3 days (bottom) and negative untreated mouse splenocytes (top). Cells were stained with ab242142 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. The cells were incubated in 1x PBS containing 10% mouse serum and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody ab242142 (1x 106 in 100μl at 0.2 μg/ml (1/10,500)) for 30min on ice. The cells were simultaneously stained with CD19.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/2000 for 30min on ice.
Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
관련 conjugated 항체와 다양한 조성의 항체 (3)
-
Anti-CD86 antibody [EPR22958-106] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD86 antibody [EPR22958-106]
-
578 PE
PE Anti-CD86 antibody [EPR22958-106]
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD86 plays a significant role in the immune system by providing secondary signals for T cell activation and differentiation. It is a part of the B7 protein family and forms a complex with CD28 and CTLA-4 on T cells. When CD86 binds to CD28 it sends positive co-stimulatory signals which promote T cell proliferation and cytokine production. On the other hand interaction with CTLA-4 transmits an inhibitory signal which reduces immune response. This dual interaction helps to balance immune activation and tolerance.
Pathways
CD86 takes part in important immune-related signaling pathways particularly the T cell receptor signaling pathway and the PI3K-Akt signaling pathway. Both pathways are fundamental for initiating immune responses. CD86's interaction with CD28 activates downstream signaling cascades including PI3K-Akt which is important for cell survival and growth. Additionally CD86 collaborates with other proteins such as CD80 another co-stimulatory molecule to amplify T cell activation within these pathways.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (8)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Materials today. Bio 33:102045 PubMed40688666
2025
Applications
Unspecified application
Species
Unspecified reactive species
IBRO neuroscience reports 18:39-49 PubMed39816480
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 12:1368021 PubMed38596358
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 17:1267-1279 PubMed38434584
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 44:213-225 PubMed36725191
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 9:897800 PubMed35911406
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:719823 PubMed34744713
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 8:1151 PubMed33241000
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com